Alembic Pharma Shares Down 5% as Board Approves Rs 1,150 Crore Impairment Charge
Shares of Alembic Pharmaceuticals hit a 52-week low of Rs 476.30 after the company said its board approved an impairment charge of Rs 1,150 crore...
Tag : US Food and Drug Administration (USFDA)
Cipla Shares Fall 4%, Near 52-Week Lows on Concerns About US Product Launch Delays
Shares of Cipla fell 4% to Rs 910.10, hitting a more than eight-month low on the BSE in intraday trade on Tuesday, amid concerns over...
Natco Pharma Gets Provisional Approval for Trabectedin For Injection
Yondelis is the brand name for an injection called Trabectedin, which has been used for antitumor chemotherapy medication to treat soft tissue sarcoma and ovarian...
Glenmark receives USFDA Preliminary Approval for Generic Psoriasis Foam
Glenmark Pharmaceuticals said Monday that its US unit had received preliminary approval from US health regulators for a generic calcipotriene and betamethasone dipropionate foam to...
Alembic Pharma Unit Receives Final USFDA Approval for Generic Version of Fever Blisters
Alembic Pharmaceuticals said Wednesday that its wholly-owned subsidiary, Aleor Dermaceuticals, has received final approval from US health regulators for its generic Docosanol cream to treat...
Lupin Slips 4% as Goa Plant Gets USFDA’s Observations
On Monday, Lupin Ltd’s shares dipped 4 per cent to Rs 913 on the BSE in intra-day trade after the pharmaceutical company said on Sunday...
Zydus Cadila Gets USFDA Tentative Nod for Epilepsy Treatment Drug
On Monday, Zydus Cadila said that they received tentative approval from the US health regulator to market epilepsy treatment drug Brivaracetam tablets. Zydus Cadila has...
Cipla Zooms 14% on USFDA Nod for Generic Proventil
Cipla Ltd shares have gained as much as 16 per cent after the company received approval from the US Food and Drug Administration (USFDA) for...